Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125448691 | 12544869 | 1 | I | 201511 | 20160629 | 20160711 | 20160711 | PER | US-TEVA-673450USA | TEVA | 48.07 | YR | M | Y | 72.64000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125448691 | 12544869 | 1 | PS | ACTIQ | FENTANYL CITRATE | 1 | Oral | 1200 MICROGRAM DAILY; | Y | UNKNOWN | 20747 | 400 | UG | LOZENGE | TID | ||||
| 125448691 | 12544869 | 2 | SS | ACTIQ | FENTANYL CITRATE | 1 | Oral | Y | UNKNOWN | 20747 | 800 | UG | LOZENGE | ||||||
| 125448691 | 12544869 | 3 | SS | ACTIQ | FENTANYL CITRATE | 1 | Oral | 200 MICROGRAM DAILY; | Y | UNKNOWN | 20747 | 200 | UG | LOZENGE | QD | ||||
| 125448691 | 12544869 | 4 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | U | 0 | 75 | UG | TRANSDERMAL PATCH | |||||||
| 125448691 | 12544869 | 5 | SS | FENTORA | FENTANYL CITRATE | 1 | U | 21947 | 600 | UG | TABLET | ||||||||
| 125448691 | 12544869 | 6 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125448691 | 12544869 | 7 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Y | 0 | |||||||||||
| 125448691 | 12544869 | 8 | C | VICODIN HP | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 125448691 | 12544869 | 9 | C | oxycodone immediate release | OXYCODONE | 1 | 0 | TABLET | |||||||||||
| 125448691 | 12544869 | 10 | C | SOMA | CARISOPRODOL | 1 | 0 | ||||||||||||
| 125448691 | 12544869 | 11 | C | EXCEDRIN | ACETAMINOPHENASPIRINCAFFEINE | 1 | 0 | ||||||||||||
| 125448691 | 12544869 | 12 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125448691 | 12544869 | 1 | Pain |
| 125448691 | 12544869 | 4 | Pain |
| 125448691 | 12544869 | 5 | Pain |
| 125448691 | 12544869 | 6 | Pain |
| 125448691 | 12544869 | 7 | Pain |
| 125448691 | 12544869 | 8 | Pain |
| 125448691 | 12544869 | 11 | Pain |
| 125448691 | 12544869 | 12 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125448691 | 12544869 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125448691 | 12544869 | Back pain | |
| 125448691 | 12544869 | Bedridden | |
| 125448691 | 12544869 | Blood pressure fluctuation | |
| 125448691 | 12544869 | Hypokinesia | |
| 125448691 | 12544869 | Neck pain | |
| 125448691 | 12544869 | Pain | |
| 125448691 | 12544869 | Peyronie's disease | |
| 125448691 | 12544869 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125448691 | 12544869 | 1 | 201507 | 201604 | 0 | |
| 125448691 | 12544869 | 2 | 2004 | 0 | ||
| 125448691 | 12544869 | 3 | 2013 | 0 | ||
| 125448691 | 12544869 | 4 | 2010 | 0 | ||
| 125448691 | 12544869 | 5 | 2008 | 0 | ||
| 125448691 | 12544869 | 7 | 2004 | 2010 | 0 |